TOBRAMYCIN SULFATE (PHARMACY BULK): Pharmaceutical manufacturers, suppliers, and packagers

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Gland	TOBRAMYCIN SULFATE (PHARMACY BULK)	tobramycin sulfate	INJECTABLE;INJECTION	209346	ANDA	Gland Pharma Limited	68083-241-01	1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE	2021-02-09
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: August 2, 2025

Introduction

Tobramycin sulfate, a potent aminoglycoside antibiotic, is extensively used to combat serious Gram-negative bacterial infections. As a pharmacy bulk drug, tobramycin sulfate serves as a critical component for compounding, research, and manufacturing. Identifying reliable suppliers is essential for pharmaceutical companies and healthcare providers ensuring the quality, consistency, and regulatory compliance of this essential antibiotic.

Global Market Overview

The global demand for tobramycin sulfate has surged due to its therapeutic efficacy against respiratory infections, ocular diseases, and systemic bacterial infections. The pharmaceutical industry relies heavily on suppliers who adhere to strict Good Manufacturing Practices (GMP), possess robust supply chains, and maintain rigorous quality control standards.

Major suppliers predominantly operate in North America, Europe, and Asia, with key players recognized for their high-quality active pharmaceutical ingredients (APIs) and bulk pharmaceutical chemicals (BPCs). The competitive landscape features multinational corporations, generics manufacturers, and specialized biotech firms.

Leading Suppliers of Tobramycin Sulfate (Pharmacy Bulk)

1. HIKMA Pharmaceuticals

Overview:
HIKMA Pharmaceuticals, headquartered in Jordan, is a globally recognized generic pharmaceutical manufacturer. They supply various antibiotics, including tobramycin sulfate, produced under stringent GMP standards.

Capabilities:

Cultivates an extensive API portfolio.
Provides pharmaceutical-grade tobramycin sulfate in bulk quantities.
Complies with US FDA, EMA, and other international regulations.

Key Attributes:

Proven capacity for large-scale API production.
Extensive distribution network across multiple continents.
R&D commitment to product quality enhancement.

2. Sanofi-Aventis

Overview:
Sanofi, headquartered in France, is a leading multinational with a substantial presence in antibiotics manufacturing. Their pharmaceutical raw material division supplies tobramycin sulfate as part of their antibiotic portfolio.

Capabilities:

Extensive experience in small-molecule APIs.
GMP-compliant manufacturing facilities.
Reliable supply chain integrating quality assurance protocols.

Key Attributes:

Established global distribution channels.
Regulatory expertise supporting smooth market access.

3. VHB Lifesciences

Overview:
VHB Lifesciences, based in India, specializes in producing bulk API pharmaceuticals, including tobramycin sulfate. They cater to the domestic and international markets with high-quality standards.

Capabilities:

Proven manufacturing processes aligned with cGMP standards.
Competitive pricing due to large-scale production facilities.
Robust quality management systems ensuring API purity.

Key Attributes:

Competitive lead times.
Widespread export reach.
Focus on continuous process improvement.

4. Sun Pharmaceutical Industries

Overview:
One of India's largest pharmaceutical firms, Sun Pharma produces a variety of antibiotics, including tobramycin sulfate, emphasizing cost-effectiveness and regulatory compliance.

Capabilities:

State-of-the-art fermentation and chemical synthesis processes.
GMP certifications compatible with global standards.
Extensive worldwide distribution.

Key Attributes:

Affordability without compromising quality.
Dedicated R&D for API innovation.

5. Jiangsu Hengrui Medicine Co., Ltd.

Overview:
A leading Chinese pharmaceutical manufacturer, Jiangsu Hengrui supplies bulk tobramycin sulfate, leveraging advanced biotechnological manufacturing methods.

Capabilities:

High-volume production capacities.
Focus on quality assurance in compliance with international standards.
Strong presence in Asian markets and expanding globally.

Selection Criteria for Suppliers

Choosing an appropriate supplier for tobramycin sulfate bulk requires evaluating several factors:

Regulatory Compliance: Certification compliance with FDA, EMA, and other relevant agencies.
Manufacturing Standards: GMP, ISO certifications, and quality control protocols.
Supply Reliability: Consistency in delivery schedules and minimum order quantities.
Product Purity & Specifications: API strength, residual solvents, endotoxin levels, etc.
Pricing & Lead Times: Competitive pricing aligned with budget constraints and production timelines.
Technical Support & Documentation: Access to stability data, certificates of analysis, and technical assistance.

Market Trends Influencing Supplier Selection

Regulatory Stringency: Increasing global regulatory standards necessitate compliance to avoid legal and market access issues.
Supply Chain Resilience: The COVID-19 pandemic underscored the importance of diversified sourcing to prevent shortages.
Quality Over Cost: Growing emphasis on API purity and batch-to-batch consistency over purely economic considerations.
Emerging Markets: Countries like India and China dominate API manufacturing, driven by cost efficiencies and expanding capacity.

Conclusion

Securing a reliable supplier for tobramycin sulfate (pharmacy bulk) is pivotal for pharmaceutical entities aiming to maintain production continuity and meet regulatory demands. Leading suppliers such as HIKMA Pharmaceuticals, Sanofi-Aventis, VHB Lifesciences, Sun Pharma, and Jiangsu Hengrui Medicine exemplify industry standards for quality, capacity, and compliance. Thorough vetting based on regulatory adherence, supply reliability, product specifications, and cost will optimize procurement strategies and safeguard production pipelines.

Key Takeaways

The global market for pharmacy bulk tobramycin sulfate is supported by reputable suppliers primarily in North America, Europe, and Asia.
Quality assurance, GMP compliance, and regulatory certifications are paramount in supplier selection.
Diversifying sourcing across multiple suppliers reduces risk amidst supply chain disruptions.
Competitive pricing should balance quality standards and logistical capabilities.
Continuous monitoring of regulatory landscapes and technological innovations enhances supply chain resilience.

Frequently Asked Questions (FAQs)

1. What are the primary regulatory considerations when sourcing tobramycin sulfate bulk?
Manufacturers must ensure suppliers hold GMP certifications, comply with FDA and EMA standards, provide comprehensive Certificates of Analysis (CoA), and maintain strict quality control measures to meet regulatory requirements.

2. How does supplier location impact the procurement of pharmacy bulk tobramycin sulfate?
Proximity affects logistics, lead times, and import/export compliance. Suppliers in regulated markets like India, China, Europe, or North America often meet stringent quality standards, influencing reliable supply.

3. What should be prioritized when selecting a supplier for bulk tobramycin sulfate?
Priorities include product purity, consistent supply, adherence to regulatory standards, cost-effectiveness, and technical support capabilities.

4. Can domestic suppliers meet global standards for tobramycin sulfate?
Yes, many domestic suppliers in countries like India and China operate GMP-certified facilities, compliant with international regulations, and are increasingly trusted for global supply chains.

5. How is supply chain resilience managed for critical antibiotic APIs?
Companies diversify their supplier base, establish long-term partnerships, maintain safety stock, and monitor geopolitical and regulatory developments to mitigate disruption risks.

Sources

[1] International Pharmaceutical Regulators Forum (IPRF). "Guidelines for GMP compliance."
[2] MarketWatch. "Global Antibiotics Market Analysis."
[3] U.S. Food and Drug Administration (FDA). "Regulatory requirements for active pharmaceutical ingredients."
[4] Sanofi Official Website. "API manufacturing capabilities."
[5] VHB Lifesciences Corporate Brochure.
[6] Sun Pharmaceutical Annual Reports.

Suppliers and packagers for TOBRAMYCIN SULFATE (PHARMACY BULK)